Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nantero is a nanotechnology company that pioneered the use of carbon nanotubes (CNTs) in semiconductor devices and high-performance memory. Its flagship technology, NRAM (Nanotube-based Random Access Memory), offers a unique combination of DRAM-like speed, non-volatility, and extreme durability against heat and radiation. Beyond electronics, Nantero's CNT platform is utilized in the life sciences for the development of high-sensitivity biosensors and medical diagnostic devices, including rapid antibody detection systems. The company operates primarily through a licensing model, partnering with global semiconductor and healthcare leaders to integrate its proprietary CNT processes into existing manufacturing environments. Following its acquisition by the Overview family in 2021, Nantero has shifted focus toward commercializing its technology as a product-driven entity.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nantero.